MINI FUTURE LONG - AMGEN | Market Closed - Euronext Paris 12:30:01 2024-07-15 pm EDT | ||
| 269 EUR | -0.17% |
|
| Current month | +4.68% | ||
| 1 month | +9.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-15 | 269 | -0.17% |
| 24-07-12 | 269.5 | +1.31% |
| 24-07-11 | 266 | +1.13% |
| 24-07-10 | 263 | +3.29% |
| 24-07-09 | 254.7 | +0.61% |
Real-time Euronext Paris
Last update July 15, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| 5087N | |
| ISIN | NL0010133450 |
| Date issued | 2012-08-29 |
| Strike | 36.87 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 272.9 € |
|---|---|
| Lowest since issue | 6.3 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- 5087N Certificat
